Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoembolization of Uveal Melanoma Hepatic Metastases Using BCNU
NCT04728633Phase 2Active, not recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine in Uveal melanoma (UM), sponsored by Thomas Jefferson University. Started Sep 2021; status: active, not recruiting.
02
Drugs
carmustine
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT04728633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728633.